370880-87-8 Usage
Uses
Used in Pharmaceutical Industry:
3-CBZ-3,6-Diazabicyclo[3.2.0]heptane is used as a chiral auxiliary in asymmetric synthesis for the production of enantiomerically pure compounds. Its ability to induce chirality in the synthesis process is crucial for the development of pharmaceuticals with specific biological activities and reduced side effects.
Used in Organic Synthesis:
3-CBZ-3,6-Diazabicyclo[3.2.0]heptane is used as a building block for the synthesis of various organic compounds. Its versatile structure allows for the creation of a wide range of molecules with different properties and applications, contributing to the advancement of organic chemistry.
Used in Transition Metal-Catalyzed Reactions:
3-CBZ-3,6-Diazabicyclo[3.2.0]heptane is used as a ligand in transition metal-catalyzed reactions. Its presence can enhance the selectivity and efficiency of these reactions, leading to the production of desired products with improved yields and purity. This application is particularly important in the synthesis of complex organic molecules and the development of new catalytic processes.
Check Digit Verification of cas no
The CAS Registry Mumber 370880-87-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,0,8,8 and 0 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 370880-87:
(8*3)+(7*7)+(6*0)+(5*8)+(4*8)+(3*0)+(2*8)+(1*7)=168
168 % 10 = 8
So 370880-87-8 is a valid CAS Registry Number.
370880-87-8Relevant articles and documents
FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS
-
Page/Page column 60, (2011/05/06)
Disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo [3.2.0]heptane compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.
FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS
-
Page/Page column 49-50, (2011/05/06)
Certain disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo [3.2.0]heptane are described, which are useful as orexin inhibitors. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.
